KMTI Hip Replacement System, Tesera Trabecular Technologies (T3) Acetabular Shell System, Porous Acetabular Cup System
K201660 is the FDA 510(k) clearance record for KMTI Hip Replacement System, Tesera Trabecular Technologies (T3) Acetabular Shell System, Porous Acetabular Cup System, a class II device, cleared for Kyocera Medical Technologies, Inc. on under FDA product code OQG (Hip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented). FDA's definition for product code OQG reads: "1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of...". FDA records list 16 510(k) clearances for Kyocera Medical Technologies, Inc., from to . As of , FDA records show no recalls naming K201660.
Clearance record
- Decision date
- Received
- (28 days to decision)
- Product code
- OQG Hip Prosthesis, Semi-Constrained, Cemented, Metal/Polymer, + Additive, Porous, Uncemented
- Regulation
- 21 CFR 888.3358
- Device class
- Class II
- Review panel
- Orthopedic
- Applicant
- Kyocera Medical Technologies, Inc. 1200 California St., Redlands CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code OQG
Trailing 12 monthsFDA records hold no clearances under product code OQG in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
